1. Home
  2. CGEN vs AP Comparison

CGEN vs AP Comparison

Compare CGEN & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$1.73

Market Cap

148.7M

Sector

Health Care

ML Signal

N/A

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

N/A

Current Price

$8.81

Market Cap

138.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CGEN
AP
Founded
1993
1929
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
148.7M
138.0M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
CGEN
AP
Price
$1.73
$8.81
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
203.5K
312.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$164.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$1.75
52 Week High
$2.38
$9.25

Technical Indicators

Market Signals
Indicator
CGEN
AP
Relative Strength Index (RSI) 44.73 70.47
Support Level $1.47 $2.39
Resistance Level $1.72 N/A
Average True Range (ATR) 0.09 0.78
MACD -0.01 0.09
Stochastic Oscillator 45.87 85.77

Price Performance

Historical Comparison
CGEN
AP

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: